Additional file 2 of Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression

Additional file 2: Supplementary Table 2. Subclasses of GO terms in the biological process (BP), molecular function (MF), and cellular compartment (CC) categories in SB2−/−;PyMT tumors compared to PyMT tumors

Additional file 1 of Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression

Additional file 1: Supplementary Table 1. 305 DEGs including upregulated and downregulated genes in SB2−/−;PyMT tumors

Additional file 5 of Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression

Additional file 5: Supplementary Data 1. Whole gel and membrane images for Fig. 1A, B

Additional file 4 of Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression

Additional file 4: Supplementary Table 4. Specific primer sequences for qRT-PCR

Additional file 3 of Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression

Additional file 3: Supplementary Table 3. Detailed information of the DEGs associated with the functional categories regulated by SerpinB2 in SB2−/−;PyMT compared to PyMT

Additional file 1 of Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study

Additional file 1: Table S1. The acceptance rate of BRCA tests conducted based on different testing criteria. Table S2. Description: 5-year and 10-year overall survival in each group. Table S3. 5-year and 10-year cumulative incidence of contralateral breast cancer

Location of Tumors in 3D Coordinates.

<p>Data are mean values, with 95% confidence intervals in parentheses.</p><p>^aRanges are (−0.5–0.5) for X- and Z-axes distances from the posterior nipple line and (0–1.0) for Y-axis distance from the chest wall.</p><p>Location of Tumors in 3D Coordinates.</p

Distribution of Tumor Location.

<p>Data are numbers of patients and numbers in parentheses are percentages</p><p>^aChi-square test for trend.</p><p>Distribution of Tumor Location.</p

Clinicopathologic Characteristics.

<p>Unless otherwise indicated, data are numbers of patients and numbers in parentheses are percentages.</p><p>^aData are mean values, with ranges in parentheses.</p><p>^bChi-square test for trend.</p><p>Clinicopathologic Characteristics.</p

A triple-negative breast cancer in the posterior location.

<p>A triple-negative breast cancer in the posterior location of the right breast in a 41-year-old woman. (A) Sagittal early contrast-enhanced nonsubtracted T1-weighted MR image with fat suppression shows a 1.5 cm round mass (arrow) with rim enhancement. Note the tumor location in the immediate prepectoral region. (B) Mass (arrow) is also seen on subtracted axial reformatted image.</p